RxDoctor Payments DataLook up a doctor →

Bertrand Kaper, MD

Orthopaedic Surgery · Scottsdale, AZNPI 1164497723

Payments from drug & device makers

$567,345in general payments, 2019–2025

Across 495 payments — averaging $1146.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$539K
  • Avanos Medical$25K
  • Heron Therapeutics, Inc.$2K
  • Zimmer Biomet$817
  • Davol Inc.$147
  • Stryker$57
  • plus $341 from 14 others
$1,980in research payments, 2019–2025

Across 1 payment — averaging $1980.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$2K

What the payments were for

  • Consulting fees$210,46144%
  • Speaking & faculty fees$218,71545%
  • Travel & lodging$42,9429%
  • Food & beverage$8,9542%
  • Education$6330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$567,345 in reported general payments places this provider in the 95th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$602,194
Medicare patients
820
Services billed
1,548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam39$33

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →